🫁 Allergic Trigger Avoidance Simulator

High Allergen Exposure in the Home

Pollen, dust mites, and dander accumulate with no avoidance in place.

• 3: Indoor allergen sources (pollen, mites, dander)
• 100–500: Dust mites per gram dust (typical mattress sample)
• >1,000: Pollen count (high season) (grains per m³ air)
• >90%: Homes with detectable dander (even without pets)

Three major indoor triggers

Pollen drifts indoors through open windows.

Dust mites thrive in bedding, carpet, and upholstery.

Pet dander sheds continuously from skin and saliva.

Unfiltered homes let all three triggers accumulate together.

Why exposure keeps climbing

Closed windows trap pollen tracked in on clothing.

Warm, humid rooms favor mite reproduction.

Carpets and soft furnishings hold dander for months.

Who is most at risk

Sensitized individuals react at far lower doses.

Children and asthmatics show earliest symptoms.

Repeated exposure primes the immune system further.

Allergen Inhalation & IgE-Mediated Degranulation

Inhaled allergens bind IgE on mast cells lining the airway.

• <1 sec: IgE binding time (allergen to receptor)
• ~10,000: Mast cells in airway mucosa (per mm² tissue)
• Seconds: Degranulation onset (after allergen contact)
• >20: Mediators released (histamine, tryptase, cytokines)

IgE cross-linking triggers the cell

Allergen binds two adjacent IgE molecules on mast cells.

Cross-linking signals calcium influx into the cell.

Granules fuse with the membrane and burst open.

One allergen exposure can degranulate thousands of mast cells at once.

What gets released

Histamine causes rapid vessel and muscle response.

Leukotrienes and prostaglandins follow within minutes.

Cytokines recruit further inflammatory cells.

Sensitization versus reaction

Sensitization primes IgE production over prior exposures.

Each new inhalation now triggers a faster response.

Repeat triggers shorten the reaction latency further.

Bronchospasm — Histamine & Leukotriene Response

Released mediators contract smooth muscle and narrow the airway.

• Up to 50%: Airway diameter reduction (during acute spasm)
• ~5 min: Histamine peak effect (after release)
• 1,000×: Leukotriene potency (histamine for bronchoconstriction)
• 2–4×: Airway resistance rise (baseline during episode)

Smooth muscle contraction

Histamine binds H1 receptors on bronchial muscle.

Muscle fibers contract, narrowing the airway lumen.

Mucus secretion increases, narrowing the passage further.

Leukotrienes act far slower but far more powerfully than histamine.

Symptoms during an episode

Wheezing signals turbulent airflow through narrowed airways.

Chest tightness reflects rising airway resistance.

Shortness of breath follows reduced airflow.

Repeated episodes and airway remodeling

Frequent bronchospasm thickens airway smooth muscle over time.

Chronic inflammation lowers the reaction threshold further.

Unmanaged triggers raise long-term asthma severity.

Avoidance Measures — Filtration, Covers, Pet Exclusion

Targeted avoidance measures cut allergen exposure at the source.

• 99.97%: HEPA filter efficiency (particles ≥0.3 micron)
• ~90%: Mite-proof cover reduction (mattress allergen exposure)
• ~80%: Pet exclusion effect (dander reduction, bedroom)
• 50–70%: Combined avoidance benefit (fewer symptom days)

HEPA filtration

HEPA filters trap pollen and dander particles.

Continuous air exchange lowers ambient allergen concentration.

Bedroom units give the greatest overnight benefit.

Combining all three measures compounds the exposure reduction.

Mite-proof bedding covers

Encasements block mite allergen from reaching the sleeper.

Hot washing bedding weekly kills remaining mites.

Low humidity further limits mite reproduction.

Pet exclusion zones

Keeping pets out of bedrooms lowers dander load.

Regular pet bathing reduces shed allergen further.

Vacuuming with HEPA bags removes settled dander.

Reduced Symptom Burden After Avoidance

Sustained avoidance lowers allergen load and bronchospasm frequency.

• ~75%: Episode frequency drop (with high compliance)
• ~60%: Airway reactivity decline (after weeks of avoidance)
• −50%: Rescue inhaler use (reported in trials)
• Significant: Sleep quality improvement (reduced nighttime symptoms)

Lower baseline reactivity

Reduced allergen contact lowers airway sensitivity.

Mast cells degranulate less often over time.

Fewer triggers mean fewer inflammatory flare-ups.

Consistent avoidance compounds benefits over weeks, not days.

Fewer bronchospasm episodes

Episode count falls as allergen load stays low.

Severity of remaining episodes also decreases.

Medication reliance drops alongside episode frequency.

Maintaining long-term control

Ongoing filtration and cleaning sustain low exposure.

Seasonal pollen spikes still require extra vigilance.

Regular review keeps avoidance measures effective.